Page last updated: 2024-10-19

melatonin and Neuroblastoma

melatonin has been researched along with Neuroblastoma in 73 studies

Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)

Research Excerpts

ExcerptRelevanceReference
" In the present study, we aimed to examine the protective effect of melatonin against hyperglycemia-induced alterations in the amyloidogenic pathway."8.12Melatonin Attenuates High Glucose-Induced Changes in Beta Amyloid Precursor Protein Processing in Human Neuroblastoma Cells. ( Boontem, P; Chaopae, W; Govitrapong, P; Nopparat, C; Sopha, P; Wongchitrat, P, 2022)
"This study was designed to assess oxidative stress induction in human neuroblastoma SH-SY5Y cells in response to cyfluthrin exposure."7.91Oxidative stress and related gene expression effects of cyfluthrin in human neuroblastoma SH-SY5Y cells: Protective effect of melatonin. ( Anadón, A; Ares, I; Lopez-Torres, B; Martínez, M; Martínez, MA; Martínez-Larrañaga, MR; Rodríguez, JL, 2019)
" Herein, we exposed mouse neuroblastoma cells (Neuro-2a cells) to different concentrations of cadmium chloride (CdCl2 ) (12."7.83Melatonin antagonizes cadmium-induced neurotoxicity by activating the transcription factor EB-dependent autophagy-lysosome machinery in mouse neuroblastoma cells. ( Chen, C; Chen, X; Guo, P; He, M; Li, G; Li, M; Li, Y; Lu, Y; Pi, H; Reiter, RJ; Tian, L; Tu, M; Xie, J; Xu, S; Yang, M; Yang, Z; Yu, Z; Zhang, L; Zhang, Y; Zhong, M; Zhou, Z, 2016)
" In this study, we investigated an important role of calpain-dependent cascades in methamphetamine-induced toxicity in human dopaminergic neuroblastoma SH-SY5Y cultured cell lines."7.76The protective effect of melatonin on methamphetamine-induced calpain-dependent death pathway in human neuroblastoma SH-SY5Y cultured cells. ( Chetsawang, B; Govitrapong, P; Phansuwan-Pujito, P; Suwanjang, W, 2010)
"Several studies demonstrated that methamphetamine (MA)-treated human neuroblastoma cells exhibit increased oxidative stress, which regulates intracellular signaling cascades leading to cell death."7.75Melatonin reduces induction of Bax, caspase and cell death in methamphetamine-treated human neuroblastoma SH-SY5Y cultured cells. ( Chetsawang, B; Govitrapong, P; Phansuwan-Pujito, P; Wisessmith, W, 2009)
" Since carvedilol and melatonin act as free-radical scavengers, this study examined the effect of carvedilol (10(-5) M) and melatonin (10(-5) M) on oxidative and cell damage induced by 3NP in N1E-115 neuroblastoma cells."7.75Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma. ( Collado, JA; Espínola, C; Feijóo, M; Gómez, MM; Medina, FJ; Montilla, P; Moreno, E; Muñoz, C; Muntané, J; Ruiz, C; Tasset, I; Túnez, I, 2009)
"Neuroprotective effects of melatonin against oxidative stress-induced neuronal cell degeneration in human SH-SY5Y neuroblastoma cells were investigated in this report."7.75Protection against cell death and sustained tyrosine hydroxylase phosphorylation in hydrogen peroxide- and MPP-treated human neuroblastoma cells with melatonin. ( Chetsawang, B; Chetsawang, J; Govitrapong, P, 2009)
" Employing human neuroblastoma cells, we found that 10 nM calyculin A (CA), a selective inhibitor of PP-2A and PP-1, significantly increased phosphorylation and accumulation of neurofilament (NF) in the cells."7.72Melatonin protects SH-SY5Y neuroblastoma cells from calyculin A-induced neurofilament impairment and neurotoxicity. ( Deng, YQ; Li, SP; Wang, JZ; Wang, XC; Wang, YP, 2004)
" In this study we demonstrate that melatonin, a pineal hormone with recently established antioxidant properties, is remarkably effective in preventing death of cultured neuroblastoma cells as well as oxidative damage and intracellular Ca2+ increases induced by a cytotoxic fragment of Abeta."7.69Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. ( Bick, RJ; Efthimiopoulos, S; Hickson-Bick, DL; Omar, RA; Pappolla, MA; Reiter, RJ; Robakis, NK; Sos, M, 1997)
"Since melatonin has direct inhibitory effects on some tumor cells in vitro, the aim of the present work was to study whether the growth and structural characteristics of the human neuroblastoma cell line SK-N-SH in vitro are influenced by this indoleamine."7.69Effects of melatonin on the proliferation and differentiation of human neuroblastoma cells in culture. ( Cos, S; Crespo, D; Fernández-Viadero, C; Megías, M; Verduga, R, 1996)
"Neuroblastoma is a deadly and serious malignancy among children."6.72Melatonin and neuroblastoma: a novel therapeutic approach. ( Hosseinzadeh, A; Kamali, M; Mehrzadi, S; Pourhanifeh, MH, 2021)
"Melatonin plays a protective role against Aβ-induced inflammation via an inflammasome-associated mechanism that is essential in inducing the active forms of cytokines and pyroptosis."5.91The role of melatonin in amyloid beta-induced inflammation mediated by inflammasome signaling in neuronal cell lines. ( Boontor, A; Govitrapong, P; Kutpruek, S; Nopparat, C, 2023)
"Pretreatment with melatonin significantly reversed METH-induced APP-cleaving secretases and Aβ production."5.72Melatonin Attenuates Methamphetamine-Induced Alteration of Amyloid β Precursor Protein Cleaving Enzyme Expressions via Melatonin Receptor in Human Neuroblastoma Cells. ( Boontor, A; Govitrapong, P; Nopparat, C; Panmanee, J, 2022)
"Melatonin has anti-angiogenic effects at different steps of the angiogenic process in SH-SY5Y neuroblastoma cells, through the downregulation of VEGF."5.46Melatonin inhibits angiogenesis in SH-SY5Y human neuroblastoma cells by downregulation of VEGF. ( Alonso-González, C; Cos, S; González, A; González-González, A; Martínez-Campa, C; Menéndez-Menéndez, J, 2017)
"Melatonin treatment for 24-h decreased the levels of phospho-ERK1/2, but significantly increased Akt phosphorylation and protein expression of the histone acetyltransferase, p300."5.42Epigenetic mechanisms of melatonin action in human SH-SY5Y neuroblastoma cells. ( Niles, LP; Pan, Y, 2015)
"Melatonin is a potent free radical scavenger, antioxidant and neuroprotective drug."5.36Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells. ( Egea, J; García, AG; López, MG; Romero, A, 2010)
"Melatonin pre-treatment reversed the deleterious effects of cobalt."5.31Melatonin protects SHSY5Y neuroblastoma cells from cobalt-induced oxidative stress, neurotoxicity and increased beta-amyloid secretion. ( Baysang, G; Brockhaus, M; Hess, C; Ly, C; Meier, F; Müller-Spahn, F; Olivieri, G; Savaskan, E, 2001)
"Findings will provide timely information on the safety, efficacy, and optimal dosing of t-PA to treat moderate/severe COVID-19-induced ARDS, which can be rapidly adapted to a phase III trial (NCT04357730; FDA IND 149634)."4.21 ( Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y, 2022)
" In the present study, we aimed to examine the protective effect of melatonin against hyperglycemia-induced alterations in the amyloidogenic pathway."4.12Melatonin Attenuates High Glucose-Induced Changes in Beta Amyloid Precursor Protein Processing in Human Neuroblastoma Cells. ( Boontem, P; Chaopae, W; Govitrapong, P; Nopparat, C; Sopha, P; Wongchitrat, P, 2022)
"This study was designed to assess oxidative stress induction in human neuroblastoma SH-SY5Y cells in response to cyfluthrin exposure."3.91Oxidative stress and related gene expression effects of cyfluthrin in human neuroblastoma SH-SY5Y cells: Protective effect of melatonin. ( Anadón, A; Ares, I; Lopez-Torres, B; Martínez, M; Martínez, MA; Martínez-Larrañaga, MR; Rodríguez, JL, 2019)
" Herein, we exposed mouse neuroblastoma cells (Neuro-2a cells) to different concentrations of cadmium chloride (CdCl2 ) (12."3.83Melatonin antagonizes cadmium-induced neurotoxicity by activating the transcription factor EB-dependent autophagy-lysosome machinery in mouse neuroblastoma cells. ( Chen, C; Chen, X; Guo, P; He, M; Li, G; Li, M; Li, Y; Lu, Y; Pi, H; Reiter, RJ; Tian, L; Tu, M; Xie, J; Xu, S; Yang, M; Yang, Z; Yu, Z; Zhang, L; Zhang, Y; Zhong, M; Zhou, Z, 2016)
" In APP-expressing neuroblastoma cells in culture, mitochondrial function was restored by melatonin or by the structurally related compounds indole-3-propionic acid or N(1)-acetyl-N(2)-formyl-5-methoxykynuramine."3.77Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling. ( Arendash, GW; Bradshaw, PC; Buzzeo, R; Cao, C; Copes, N; Dragicevic, N; Jin, J; Mamcarz, M; O'Neal-Moffitt, G; Olcese, JM; Tan, J, 2011)
" In this study, we investigated an important role of calpain-dependent cascades in methamphetamine-induced toxicity in human dopaminergic neuroblastoma SH-SY5Y cultured cell lines."3.76The protective effect of melatonin on methamphetamine-induced calpain-dependent death pathway in human neuroblastoma SH-SY5Y cultured cells. ( Chetsawang, B; Govitrapong, P; Phansuwan-Pujito, P; Suwanjang, W, 2010)
"The combined use (MDB) of Somatostatin, Melatonin, Retinoids, Vitamins E, C, and D3, with Calcium, Chondroitin sulfate, and microdoses of Cyclophosphamide in a seven-month old baby affected by a voluminous retroperitoneal neuroblastoma measuring 4 x 8 cm produced a 50% objective response in six months, an almost total response in one year and a complete response at 14 months, with cure and absence of disease for over ten years."3.75Complete objective response of neuroblastoma to biological treatment. ( Colori, B; Di Bella, G, 2009)
" Since carvedilol and melatonin act as free-radical scavengers, this study examined the effect of carvedilol (10(-5) M) and melatonin (10(-5) M) on oxidative and cell damage induced by 3NP in N1E-115 neuroblastoma cells."3.75Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma. ( Collado, JA; Espínola, C; Feijóo, M; Gómez, MM; Medina, FJ; Montilla, P; Moreno, E; Muñoz, C; Muntané, J; Ruiz, C; Tasset, I; Túnez, I, 2009)
"Neuroprotective effects of melatonin against oxidative stress-induced neuronal cell degeneration in human SH-SY5Y neuroblastoma cells were investigated in this report."3.75Protection against cell death and sustained tyrosine hydroxylase phosphorylation in hydrogen peroxide- and MPP-treated human neuroblastoma cells with melatonin. ( Chetsawang, B; Chetsawang, J; Govitrapong, P, 2009)
"Several studies demonstrated that methamphetamine (MA)-treated human neuroblastoma cells exhibit increased oxidative stress, which regulates intracellular signaling cascades leading to cell death."3.75Melatonin reduces induction of Bax, caspase and cell death in methamphetamine-treated human neuroblastoma SH-SY5Y cultured cells. ( Chetsawang, B; Govitrapong, P; Phansuwan-Pujito, P; Wisessmith, W, 2009)
" The aim of our study was to determine gene-protein pathways of the antioxidants, dopamine (DA), R-apomorphine (R-APO), melatonin, and green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG), in neuroblastoma cells, using a customized cDNA microarray and quantitative reverse transcriptase-polymerase chain reaction gene expression techniques."3.72cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells. ( Mandel, S; Weinreb, O; Youdim, MB, 2003)
" Since melatonin acts by both enlarging microtubules and as a free-radical scavenger, in this work we studied the effects of melatonin on altered cytoskeletal organization induced by OA in N1E-115 neuroblastoma cells."3.72Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in N1E-115 cells. ( Antón-Tay, F; Bellon, A; Benitez-King, G; Ortíz, GG; Túnez, I, 2003)
"We generated a neuroblastoma (SH-SY5Y) cell system in which cytoskeletal proteins are abnormally phosphorylated resulting in microtubule disruption due to the marked inhibition of protein phosphatase activities by okadaic acid (OA)."3.72Melatonin ameliorated okadaic-acid induced Alzheimer-like lesions. ( Li, XT; Liu, SJ; Wang, JZ; Wang, XC; Wang, YP; Zhou, XW, 2004)
" Employing human neuroblastoma cells, we found that 10 nM calyculin A (CA), a selective inhibitor of PP-2A and PP-1, significantly increased phosphorylation and accumulation of neurofilament (NF) in the cells."3.72Melatonin protects SH-SY5Y neuroblastoma cells from calyculin A-induced neurofilament impairment and neurotoxicity. ( Deng, YQ; Li, SP; Wang, JZ; Wang, XC; Wang, YP, 2004)
"To explore if protective effect of melatonin on oxidative stress induced by okadaic acid, an inhibitor of protein phosphatases PP1 and PP2A, is mediated by membrane receptors subtype mt1, we used an in vitro model with N1E-115 neuroblastoma cells."3.72Effect of melatonin on the oxidative stress in N1E-115 cells is not mediated by mt1 receptors. ( Bujalance, I; Feijóo, M; Montilla, P; Muñoz, MC; Muñoz-Castañeda, JR; Túnez, I, 2003)
"Physiological concentrations of the pineal hormone melatonin induce an increase of microtubules in neuroblastoma NIE-115 cells."3.69Effect of melatonin on beta-tubulin and MAP2 expression in NIE-115 cells. ( Maldonado, V; Meléndez, J; Ortega, A, 1996)
" In this study we demonstrate that melatonin, a pineal hormone with recently established antioxidant properties, is remarkably effective in preventing death of cultured neuroblastoma cells as well as oxidative damage and intracellular Ca2+ increases induced by a cytotoxic fragment of Abeta."3.69Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. ( Bick, RJ; Efthimiopoulos, S; Hickson-Bick, DL; Omar, RA; Pappolla, MA; Reiter, RJ; Robakis, NK; Sos, M, 1997)
"Melatonin plays a protective role against Aβ-induced inflammation via an inflammasome-associated mechanism that is essential in inducing the active forms of cytokines and pyroptosis."1.91The role of melatonin in amyloid beta-induced inflammation mediated by inflammasome signaling in neuronal cell lines. ( Boontor, A; Govitrapong, P; Kutpruek, S; Nopparat, C, 2023)
"Melatonin is a potent antioxidant that has the beneficial ability to prevent neurodegenerative diseases like PD."1.72Melatonin attenuates MPP ( Choi, H; Jung, YJ; Oh, E, 2022)
"Pretreatment with melatonin significantly reversed METH-induced APP-cleaving secretases and Aβ production."1.72Melatonin Attenuates Methamphetamine-Induced Alteration of Amyloid β Precursor Protein Cleaving Enzyme Expressions via Melatonin Receptor in Human Neuroblastoma Cells. ( Boontor, A; Govitrapong, P; Nopparat, C; Panmanee, J, 2022)
"Melatonin treatment for 24-h decreased the levels of phospho-ERK1/2, but significantly increased Akt phosphorylation and protein expression of the histone acetyltransferase, p300."1.42Epigenetic mechanisms of melatonin action in human SH-SY5Y neuroblastoma cells. ( Niles, LP; Pan, Y, 2015)
"Melatonin is a potent free radical scavenger, antioxidant and neuroprotective drug."1.36Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells. ( Egea, J; García, AG; López, MG; Romero, A, 2010)
" Melatonin, a free radical scavenger, blocks tau hyperphosphorylation, and microtubule disorganization caused by haloperidol in a dose-response mode."1.36Haloperidol causes cytoskeletal collapse in N1E-115 cells through tau hyperphosphorylation induced by oxidative stress: Implications for neurodevelopment. ( Benítez-King, G; Jiménez-Rubio, G; Ortíz-López, L; Ramírez-Rodríguez, G, 2010)
"Wortmannin is an effective tool for reproducing Alzheimer-like tau hyperphosphorylation cell model and melatonin/vitamin E can effectively protect the cells from wortmannin-induced impairments."1.33Effects of melatonin on wortmannin-induced tau hyperphosphorylation. ( Deng, YQ; Duan, P; Wang, JZ; Xu, GG; Zhang, Q, 2005)
"Melatonin (MLT) has received much attention in recent years due to its direct free radical scavenging and antioxidant properties."1.31Melatonin regulation of antioxidant enzyme gene expression. ( Antoli, I; Herrera, F; Martin, V; Mayo, JC; Rodriguez, C; Sainz, RM, 2002)
"Melatonin can partly inhibit the cytotoxicity of H2O2 and Abeta through its role as a free radical scavenger."1.31Protective effect of melatonin on neural cells against the cytotoxicity of oxyradicals. ( An, Y; Dai, Q; Han, F; Liu, E; Liu, X; Yang, F, 2000)
"Melatonin pre-treatment reversed the deleterious effects of cobalt."1.31Melatonin protects SHSY5Y neuroblastoma cells from cobalt-induced oxidative stress, neurotoxicity and increased beta-amyloid secretion. ( Baysang, G; Brockhaus, M; Hess, C; Ly, C; Meier, F; Müller-Spahn, F; Olivieri, G; Savaskan, E, 2001)
"Melatonin was found to potentiate the nerve growth factor-mediated differentiation in PC12 cells at 24 h."1.30Melatonin alters the metabolism of the beta-amyloid precursor protein in the neuroendocrine cell line PC12. ( Lahiri, DK; Song, W, 1997)
"Normelatonin was more protective against hydrogen peroxide (H2O2) and glutamate-induced cell death in SK-N-MC cells compared to melatonin which was more effective to protect primary cerebellar granular neurons against the toxicity of H2O2, glutamate and N-methyl-D-aspartate when compared to normelatonin."1.30N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-kappaB. ( Behl, C; Lezoualc'h, F; Sparapani, M, 1998)

Research

Studies (73)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's10 (13.70)18.2507
2000's28 (38.36)29.6817
2010's22 (30.14)24.3611
2020's13 (17.81)2.80

Authors

AuthorsStudies
Luo, XT1
Wang, CM1
Liu, Y3
Huang, ZG1
Malek, R2
Arribas, RL1
Palomino-Antolin, A1
Totoson, P1
Demougeot, C1
Kobrlova, T1
Soukup, O1
Iriepa, I2
Moraleda, I2
Diez-Iriepa, D1
Godyń, J1
Panek, D1
Malawska, B1
Głuch-Lutwin, M1
Mordyl, B1
Siwek, A1
Chabchoub, F2
Marco-Contelles, J2
Kiec-Kononowicz, K1
Egea, J2
de Los Ríos, C1
Ismaili, L2
Nopparat, C4
Boontor, A2
Panmanee, J2
Govitrapong, P16
Merlo, S1
Caruso, GI1
Bonfili, L1
Spampinato, SF1
Costantino, G1
Eleuteri, AM1
Sortino, MA1
Jung, YJ1
Choi, H1
Oh, E1
Kim, MJ1
Choi, GE1
Chae, CW1
Lim, JR1
Jung, YH1
Yoon, JH1
Park, JY1
Han, HJ1
Kitidee, K1
Samutpong, A1
Pakpian, N1
Wisitponchai, T1
Reiter, RJ3
Wongchitrat, P2
Balpınar, Ö1
Nadaroğlu, H1
Hacımüftüoğlu, A1
Kutpruek, S1
Huang, Y2
Liang, B1
Li, Z3
Zhong, Y1
Wang, B1
Zhang, B3
Du, J1
Ye, R1
Xian, H1
Min, W1
Yan, X3
Deng, Y1
Feng, Y1
Bai, R1
Fan, B1
Yang, X2
Huang, Z1
Maj, M1
Wnorowski, A1
Jóźwiak, K1
Martin, H1
Srivastava, AK1
Roy Choudhury, S1
Karmakar, S1
Shukla, M2
Chinchalongporn, V1
Nese, M1
Riboli, G1
Brighetti, G1
Sassi, V1
Camela, E1
Caselli, G1
Sassaroli, S1
Borlimi, R1
Aucoin, M1
Cooley, K1
Saunders, PR1
Carè, J1
Anheyer, D1
Medina, DN1
Cardozo, V1
Remy, D1
Hannan, N1
Garber, A1
Velayos, M1
Muñoz-Serrano, AJ1
Estefanía-Fernández, K1
Sarmiento Caldas, MC1
Moratilla Lapeña, L1
López-Santamaría, M1
López-Gutiérrez, JC1
Li, J1
Zhang, J1
Shen, S1
Yu, WW1
Toyoda, H1
Huang, DQ1
Le, MH1
Nguyen, MH1
Huang, R1
Zhu, L1
Wang, J7
Xue, L1
Liu, L2
Huang, S1
Li, Y7
Xu, T1
Li, C2
Ji, F1
Ming, F1
Zhao, Y2
Cheng, J1
Wang, Y3
Zhao, H1
Hong, S1
Chen, K2
Zhao, XA1
Zou, L1
Sang, D1
Shao, H1
Guan, X1
Chen, X3
Chen, Y4
Wei, J1
Zhu, C1
Wu, C1
Moore, HB1
Barrett, CD1
Moore, EE1
Jhunjhunwala, R1
McIntyre, RC1
Moore, PK1
Hajizadeh, N1
Talmor, DS1
Sauaia, A1
Yaffe, MB1
Liu, C3
Lin, Y1
Dong, Y1
Wu, Y1
Bao, Y1
Yan, H2
Ma, J1
Fernández-Cuadros, ME1
Albaladejo-Florín, MJ1
Álava-Rabasa, S1
Usandizaga-Elio, I1
Martinez-Quintanilla Jimenez, D1
Peña-Lora, D1
Neira-Borrajo, I1
López-Muñoz, MJ1
Rodríguez-de-Cía, J1
Pérez-Moro, OS1
Abdallah, M1
Alsaleh, H1
Baradwan, A1
Alfawares, R1
Alobaid, A1
Rasheed, A1
Soliman, I1
Wendel Garcia, PD1
Fumeaux, T1
Guerci, P1
Heuberger, DM1
Montomoli, J2
Roche-Campo, F1
Schuepbach, RA1
Hilty, MP1
Poloni, TE1
Carlos, AF1
Cairati, M1
Cutaia, C1
Medici, V1
Marelli, E1
Ferrari, D1
Galli, A1
Bognetti, P1
Davin, A1
Cirrincione, A1
Ceretti, A1
Cereda, C1
Ceroni, M1
Tronconi, L1
Vitali, S1
Guaita, A1
Leeds, JS1
Raviprakash, V1
Jacques, T1
Scanlon, N1
Cundall, J1
Leeds, CM1
Riva, A1
Gray, EH1
Azarian, S1
Zamalloa, A1
McPhail, MJW1
Vincent, RP1
Williams, R1
Chokshi, S1
Patel, VC1
Edwards, LA1
Alqarawi, W1
Birnie, DH1
Golian, M1
Nair, GM1
Nery, PB1
Klein, A1
Davis, DR1
Sadek, MM1
Neilipovitz, D1
Johnson, CB1
Green, MS1
Redpath, C1
Miller, DC1
Beamer, P1
Billheimer, D1
Subbian, V1
Sorooshian, A1
Campbell, BS1
Mosier, JM1
Novaretti, JV1
Astur, DC1
Cavalcante, ELB1
Kaleka, CC1
Amaro, JT1
Cohen, M1
Huang, W1
Li, T1
Ling, Y1
Qian, ZP1
Zhang, YY1
Huang, D1
Xu, SB1
Liu, XH1
Xia, L1
Yang, Y4
Lu, SH1
Lu, HZ1
Zhang, R2
Ma, JX1
Tang, S1
Li, CM1
Wan, J1
Wang, JF1
Ma, JQ1
Luo, JJ1
Chen, HY2
Mi, SL1
Chen, SY1
Su, YG1
Ge, JB1
Milheiro, SA1
Gonçalves, J1
Lopes, RMRM1
Madureira, M1
Lobo, L1
Lopes, A1
Nogueira, F1
Fontinha, D1
Prudêncio, M1
M Piedade, MF1
Pinto, SN1
Florindo, PR1
Moreira, R1
Castillo-Lora, J1
Delley, MF1
Laga, SM1
Mayer, JM1
Sutjarit, N1
Thongon, N1
Weerachayaphorn, J1
Piyachaturawat, P1
Suksamrarn, A1
Suksen, K1
Papachristou, DJ1
Blair, HC1
Hu, Y1
Shen, P1
Zeng, N1
Wang, L3
Yan, D1
Cui, L1
Yang, K2
Zhai, C1
Yang, M2
Lao, X1
Sun, J1
Ma, N1
Wang, S1
Ye, W1
Guo, P2
Rahimi, S1
Singh, MP1
Gupta, J1
Nakanishi, I1
Ohkubo, K1
Shoji, Y1
Fujitaka, Y1
Shimoda, K1
Matsumoto, KI1
Fukuhara, K1
Hamada, H1
van der Boom, T1
Gruppen, EG1
Lefrandt, JD1
Connelly, MA1
Links, TP1
Dullaart, RPF1
Berry, JD1
Bedlack, R1
Mathews, D1
Agnese, W1
Apple, S1
Meloncelli, S1
Divizia, M1
Germani, G1
Adefegha, SA1
Bottari, NB1
Leal, DB1
de Andrade, CM1
Schetinger, MR1
Martínez-Velasco, A1
Perez-Ortiz, AC1
Antonio-Aguirre, B1
Martínez-Villaseñor, L1
Lira-Romero, E1
Palacio-Pastrana, C1
Zenteno, JC1
Ramirez, I1
Zepeda-Palacio, C1
Mendoza-Velásquez, C1
Camacho-Ordóñez, A1
Ortiz Bibriesca, DM1
Estrada-Mena, FJ1
Martin, BL1
Thompson, LC1
Kim, YH2
Snow, SJ1
Schladweiler, MC1
Phillips, P1
Harmon, M1
King, C1
Richards, J1
George, I1
Haykal-Coates, N1
Gilmour, MI1
Kodavanti, UP1
Hazari, MS1
Farraj, AK1
Shen, Z1
Zou, Y1
Gao, K1
Lazar, S1
Wurtzel, JGT1
Ma, P1
Goldfinger, LE1
Vukelic, M1
Laloo, A1
Kyttaris, VC1
Chen, R1
Chen, J2
Xun, J1
Hu, Z1
Huang, Q2
Steinhart, C1
Shen, Y1
Lu, H1
Mansuri, A1
Lokhande, K1
Kore, S1
Gaikwad, S1
Nawani, N1
Swamy, KV1
Junnarkar, M1
Pawar, S1
Shaheen, MY1
Basudan, AM1
Niazy, AA1
van den Beucken, JJJP1
Jansen, JA1
Alghamdi, HS1
Gao, Q2
Guo, X1
Cao, Y1
Jia, X1
Xu, S2
Lu, C2
Zhu, H2
Melku, M1
Abebe, G1
Teketel, A1
Asrie, F1
Yalew, A1
Biadgo, B1
Kassa, E1
Damtie, D1
Anlay, DZ1
Ahmed, MFE1
Ramadan, H1
Seinige, D1
Kehrenberg, C1
Abd El-Wahab, A1
Volkmann, N1
Kemper, N1
Schulz, J1
Hu, MY1
Wu, YN1
McEvoy, MP1
Wang, YF1
Cong, WL1
Liu, LP1
Li, XX1
Zhou, CL1
Chen, WM1
Wei, KL1
Tung, SY1
Shen, CH1
Chang, TS1
Yen, CW1
Hsieh, YY1
Chiu, WN1
Hu, JH1
Lu, SN1
Hung, CH1
Alakavuklar, MA1
Fuqua, C1
Luo, KL1
Underwood, RS1
Greenwald, I1
Elashiry, MM1
Elashiry, M1
Zeitoun, R1
Elsayed, R1
Tian, F1
Saber, SE1
Elashry, SH1
Tay, FR1
Cutler, CW1
O'Dowd, A1
Maciel, M1
Poole, ST1
Jobling, MG1
Rollenhagen, JE1
Woods, CM1
Sincock, SA1
McVeigh, AL1
Gregory, MJ1
Maves, RC1
Prouty, MG1
Holmes, RK1
Savarino, SJ1
Mor, MK1
Palevsky, PM1
Kaufman, JS1
Thiessen Philbrook, H1
Weisbord, SD1
Parikh, CR1
John, CM1
Phillips, NJ1
Jarvis, GA1
Zhu, Y1
Kilburn, S1
Kapoor, M1
Chaturvedi, S1
Shaw, KJ1
Chaturvedi, V1
Kong, X1
Zhang, T1
Xiao, H1
Feng, X1
Tu, H1
Feng, J1
Sabet, M1
Tarazi, Z1
Griffith, DC1
Nguyen, F1
Guan, P1
Guerrero, DT1
Kolla, V1
Naraparaju, K1
Perry, LM1
Soberman, D1
Pressly, BB1
Alferiev, IS1
Chorny, M1
Brodeur, GM1
Gao, X2
Cheng, YH1
Enten, GA1
DeSantis, AJ1
Gaponenko, V1
Majetschak, M1
Kim, DY1
Choi, MJ1
Ko, TK1
Lee, NH1
Kim, OH1
Cheon, HG1
Cai, H1
Yip, V1
Lee, MV1
Wong, S1
Saad, O1
Ma, S1
Ljumanovic, N1
Khojasteh, SC1
Kamath, AV1
Shen, BQ1
Cuypers, ML1
Chanteux, H1
Gillent, E1
Bonnaillie, P1
Saunders, K1
Beckers, C1
Delatour, C1
Dell'Aiera, S1
Ungell, AL1
Nicolaï, J1
Knapp, AK1
Chen, A1
Griffin-Nolan, RJ1
Baur, LE1
Carroll, CJW1
Gray, JE1
Hoffman, AM1
Li, X4
Post, AK1
Slette, IJ1
Collins, SL1
Luo, Y1
Smith, MD1
Temitayo, GI1
Olawande, B1
Emmanuel, YO1
Timothy, AT1
Kehinde, O1
Susan, LF1
Ezra, L1
Joseph, OO1
Lev, S1
Desmarini, D1
Liuwantara, D1
Sorrell, TC1
Hawthorne, WJ1
Djordjevic, JT1
Verso, MG1
Costantino, C1
Marrella, A1
Immordino, P1
Vitale, F1
Amodio, E1
Wang, YD1
Yao, WL1
Xin, ZM1
Han, TT1
Wang, ZG1
Chen, L1
Cai, C1
Zhang, Y5
Ba, D1
Wen, S1
Tian, Q1
Lv, W1
Cheng, G1
Li, N1
Yue, XY1
Chu, WJ1
Chen, Q1
Choi, ES1
Zhao, X3
Zhou, HD1
Sun, XF1
Sharma, S2
Chhoker, S1
Xie, C1
Ong, EWY1
Tan, ZK1
Evans, S1
Weinheimer, CJ1
Kovacs, A1
Williams, JW1
Randolph, GJ1
Jiang, W1
Barger, PM1
Mann, DL1
Liu, J2
Kong, L1
Yu, X1
Feng, B1
Liu, D1
Zhao, B1
Mendes, GC1
Yuan, P1
Ge, D1
Wang, WM1
Fontes, EPB1
Li, P1
Shan, L1
He, P1
Katoh, T1
Sengoku, T1
Hirata, K1
Ogata, K1
Suga, H1
Shun, C1
Yong-Yi, J1
Mei-Li, C1
Shi-Li, L1
Jian-Bo, Z1
Dan-Li, W1
Zhi-Min, G1
Ibrahim, AM1
Zakhary, SY1
Amin, SAW1
Ugurlu, M1
Fornari, VJ1
Hartmann, MSM1
Vanni, JR1
Rodriguez, R1
Langaro, MC1
Pelepenko, LE1
Zaia, AA1
Nakanjako, D1
Zalwango, F1
Wairagala, P1
Luboga, F1
Andia Biraro, I1
Bukirwa, VD1
Mboowa, MG1
Cose, S1
Seeley, J1
Elliott, A1
Zhao, G1
Sun, P1
Hao, S1
Wang, X2
Qu, G1
Xing, Y1
Xu, X1
Maierhofer, M1
Rieger, V1
Mayr, T1
Zhang, Q2
Bigliardi, AP1
Fernandes, CLF1
Pinto, EA1
Dos Santos, M1
Garcia, EM1
Baisch, PRM1
Soares, MCF1
Muccillo-Baisch, AL1
da Silva Júnior, FMR1
Yu, W1
Ju, C1
Wang, K1
Zheng, Z1
Liu, H1
Gao, Y1
Martínez-Navarro, EM1
Cebrián-Tarancón, C1
Moratalla-López, N1
Lorenzo, C1
Alonso, GL1
Salinas, RM1
Bermúdez de Castro, JM1
Modesto-Mata, M1
Martín-Francés, L1
García-Campos, C1
Martínez de Pinillos, M1
Martinón-Torres, M1
Hasani, M1
Wu, F2
Warriner, K1
Kurz, M1
Gretzke, D1
Hörlein, R1
Turpault, S1
Atzrodt, J1
Derdau, V1
Yao, Y1
Ou, X1
Zhao, S1
Tian, B1
Jin, S1
Jiang, Z1
Zhou, Z2
Liu, M2
Jiang, GD1
Mou, LH1
Chen, JJ1
Li, ZY1
He, SG1
Reale, E1
Fustinoni, S1
Mercadante, R1
Polledri, E1
Hopf, NB1
Grant, PC1
Levy, K1
Lattimer, TA1
Depner, RM1
Kerr, CW1
Sato, J1
Merenda, MEZ1
Uemoto, AT1
Dos Santos, MP1
Barion, MRL1
Carciofi, AC1
de Paula Dorigam, JC1
Ribeiro, LB1
Vasconcellos, RS1
Waller, SB1
Peter, CM1
Hoffmann, JF1
Cleff, MB1
Faria de, RO1
Zani, JL1
Martins, BA1
Sande, D1
Solares, MD1
Takahashi, JA1
Yang, S2
Jia, Y1
Yin, C1
Zhao, R1
Ojha, M1
Wu, B1
Deepa, M1
Mo, J1
Au, DW1
Wan, MT1
Shi, J1
Zhang, G1
Winkler, C1
Kong, RY1
Seemann, F1
Bianco, M1
Calvano, CD1
Ventura, G1
Bianco, G1
Losito, I1
Cataldi, TRI1
Angiolella, L1
Staudt, A1
Duarte, PF1
Amaral, BPD1
Peixoto Andrade, BCO1
Simas, NK1
Correa Ramos Leal, I1
Sangenito, LS1
Santos, ALSD1
de Oliveira, D1
Junges, A1
Cansian, RL1
Paroul, N1
Siu, J1
Klingler, L1
Hung, CT1
Jeong, SH1
Smith, S1
Tingle, MD1
Wagner Mackenzie, B1
Biswas, K1
Douglas, RG1
Oza, AM1
Lorusso, D1
Aghajanian, C1
Oaknin, A1
Dean, A1
Colombo, N1
Weberpals, JI1
Clamp, AR1
Scambia, G1
Leary, A1
Holloway, RW1
Gancedo, MA1
Fong, PC1
Goh, JC1
O'Malley, DM1
Armstrong, DK1
Banerjee, S1
García-Donas, J1
Swisher, EM1
Cella, D1
Meunier, J1
Goble, S1
Cameron, T1
Maloney, L1
Mörk, AC1
Bedel, J1
Ledermann, JA1
Coleman, RL1
Vlek, SL1
Burm, R1
Govers, TM1
Vleugels, MPH1
Tuynman, JB1
Mijatovic, V1
Leicht, AS1
Connor, J1
Conduit, N1
Vaquera, A1
Gómez, MA1
McKay, JA1
Church, AL1
Rubin, N1
Emory, TH1
Hoven, NF1
Kuehn-Hajder, JE1
Nelson, MT1
Ramanna, S1
Auerbach, EJ1
Moeller, S1
Bolan, PJ1
Fox, NP1
Leonard, M1
Sjerps, MJ1
Chang, EF1
Hyun, S1
Saejio, A1
Shanmugam, S1
Liu, X2
Sun, M1
Bai, Z1
Jaque-Fernandez, F1
Beaulant, A1
Berthier, C1
Monteiro, L1
Allard, B1
Casas, M1
Rieusset, J1
Jacquemond, V1
Góngora-García, OR1
Aca-Aca, G1
Baz-Rodríguez, SA1
Monte, A1
Maganaris, C1
Baltzopoulos, V1
Zamparo, P1
Wang, Z3
Hou, Y1
Cai, L1
Tu, YJ1
Tan, B1
Jiang, L1
Wu, ZH1
Yu, HJ1
Li, XQ1
Yang, AD1
Titze, IR1
Palaparthi, A1
Mau, T1
González, MA1
Goiri, F1
Barandika, JF1
García-Pérez, AL1
Jatt, LP1
Gandhi, MM1
Guo, R1
Sukhija-Cohen, A1
Bhattacharya, D1
Tseng, CH1
Chew, KW1
Onwumere, J1
Pia Tek, J1
Budnyak, T1
Budnyk, S1
Karim, Z1
Thersleff, T1
Kuśtrowski, P1
Mathew, AP1
Slabon, A1
Guo, M1
Zhao, T1
Xing, Z1
Qiu, Y1
Pan, K1
Zhou, W1
Ghassemi Tabrizi, S1
Arbuznikov, AV1
Jiménez-Hoyos, CA1
Kaupp, M1
Lin, MH2
Bulman, DM1
Remucal, CK1
Chaplin, BP1
Laguerre, A1
George, LA1
Gall, ET1
Emerson, MS1
Wang, H3
Maginn, EJ1
Margulis, CJ1
Li, H2
Feng, W1
Kang, X2
Yan, S1
Chao, M1
Mo, S1
Sun, W1
Lu, Y2
Chen, C2
Stevens, DM1
Adiseshaiah, P1
Dasa, SSK1
Potter, TM1
Skoczen, SL1
Snapp, KS1
Cedrone, E1
Patel, N1
Busman-Sahay, K1
Rosen, EP1
Sykes, C1
Cottrell, M1
Dobrovolskaia, MA1
Estes, JD1
Kashuba, ADM1
Stern, ST1
Özütemiz, C1
Neil, EC1
Tanwar, M1
Rubin, NT1
Ozturk, K1
Cayci, Z1
Duscha, BD1
Kraus, WE1
Jones, WS1
Robbins, JL1
Piner, LW1
Huffman, KM1
Allen, JD1
Annex, BH1
Mehmood, T1
Ahmad, I1
Bibi, S1
Mustafa, B1
Ali, I1
Dahal, RH1
Chaudhary, DK1
Kim, DU1
Kim, J1
Yeter, HH1
Gonul, I1
Guz, G1
Helvaci, O1
Korucu, B1
Akcay, OF1
Derici, U1
Arinsoy, T1
Neffati, R1
Judeinstein, P1
Rault, J1
Xu, Y1
Chai, X1
Ren, T1
Yu, S1
Fu, Q2
Ye, J1
Ge, X1
Song, J1
Yang, H2
El-Baba, TJ1
Lutomski, CA1
Kantsadi, AL1
Malla, TR1
John, T1
Mikhailov, V1
Bolla, JR1
Schofield, CJ1
Zitzmann, N1
Vakonakis, I1
Robinson, CV1
Langham, MC1
Caporale, AS1
Wehrli, FW1
Parry, S1
Schwartz, N1
den Boer, RB1
Jones, KI1
Ash, S1
van Boxel, GI1
Gillies, RS1
O'Donnell, T1
Ruurda, JP1
Sgromo, B1
Silva, MA1
Maynard, ND1
Sivieri, EM1
Eichenwald, EC1
Rub, D1
Abbasi, S1
Krahnert, I1
Bolze, A1
Gibon, Y1
Fernie, AR1
Huang, L1
Wan, Y1
Dang, Z1
Yang, P1
Yang, Q1
Wu, S2
Lin, CC1
Hsu, CT1
Liu, W2
Huang, SC1
Kortz, U1
Mougharbel, AS1
Chen, TY1
Hu, CW1
Lee, JF1
Wang, CC1
Liao, YF1
Li, LJ1
Li, L1
Peng, S1
Stimming, U1
Hebbar Kannur, K1
Yaqub, TB1
Pupier, C1
Héau, C1
Cavaleiro, A1
Yamamoto, S1
Ono, A1
Matsui, J1
Hoshino, N1
Akutagawa, T1
Miyashita, T1
Mitsuishi, M1
Patel, SM1
Smith, TG1
Morton, M1
Stiers, KM1
Seravalli, J1
Mayclin, SJ1
Edwards, TE1
Tanner, JJ1
Becker, DF1
Butcher, TW1
Yang, JL1
Hartwig, JF1
Yu, MF1
Xia, ZZ1
Yao, JC1
Feng, Z1
Li, DH1
Liu, T1
Cheng, GJ1
He, DL1
Li, XH1
Huurman, R1
Schinkel, AFL1
de Jong, PL1
van Slegtenhorst, MA1
Hirsch, A1
Michels, M1
Kataja, A1
Tarvasmäki, T1
Lassus, J1
Sionis, A1
Mebazaa, A1
Pulkki, K1
Banaszewski, M1
Carubelli, V1
Hongisto, M1
Jankowska, E1
Jurkko, R1
Jäntti, T1
Kasztura, M1
Parissis, J1
Sabell, T1
Silva-Cardoso, J1
Spinar, J1
Tolppanen, H1
Harjola, VP1
Carsetti, A1
Damiani, E1
Casarotta, E1
Scorcella, C1
Domizi, R1
Gasparri, F1
Gabbanelli, V1
Pantanetti, S1
Carozza, R1
Adrario, E1
Donati, A1
Almada, E1
Pariani, A1
Rivabella Maknis, T1
Hidalgo, F1
Vena, R1
Favre, C1
Larocca, MC1
Lu, ZY1
Jiang, WD1
Wu, P1
Kuang, SY1
Tang, L1
Yang, J1
Zhou, XQ1
Feng, L1
Leal, M1
Zampini, IC1
Mercado, MI1
Moreno, MA1
Simirgiotis, MJ1
Bórquez, J1
Ponessa, G1
Isla, MI1
Saliu, IO1
Amoo, ZA1
Khan, MF1
Olaleye, MT1
Rema, V1
Akinmoladun, AC1
Khan, AU1
Rahman, AU1
Yuan, Q1
Ahmad, A1
Khan, ZUH1
Mahnashi, MH1
Alyami, BA1
Alqahtani, YS1
Ullah, S1
Wirman, AP1
Gao, M1
Deng, L1
Zhang, K1
Wang, M1
Xia, Z1
Gao, D1
Balkissou, AD1
Poka-Mayap, V1
Massongo, M1
Djenabou, A1
Endale-Mangamba, LM1
Olomo, EJ1
Boulleys-Nana, JR1
Diffo-Sonkoue, L1
Adidigue-Ndiome, R1
Alexandra, AJE1
Haman-Wabi, AB1
Adama, S1
Iddi-Faical, A1
Pefura-Yone, EW1
Zhao, Q1
Tong, W1
Ge, C1
Zhao, D1
Norbäck, D1
Li, B1
Zhao, Z1
Huang, C1
Zhang, X1
Qian, H1
Sun, Y1
Sundell, J1
Deng, Q1
Kim, HJ1
Jeon, JW1
Hwang, SM1
Chu, KI1
Cha, YH1
Kwak, YD1
Choi, SD1
Aslam, M1
Kim, CG1
Zhou, J1
Yang, E1
Yang, W1
Chaopae, W1
Boontem, P1
Sopha, P1
Pourhanifeh, MH1
Kamali, M1
Mehrzadi, S1
Hosseinzadeh, A1
Lee, WJ1
Chen, LC1
Lin, JH1
Cheng, TC1
Kuo, CC1
Wu, CH1
Chang, HW1
Tu, SH1
Ho, YS1
Martínez, MA1
Rodríguez, JL1
Lopez-Torres, B1
Martínez, M1
Martínez-Larrañaga, MR1
Anadón, A1
Ares, I1
Suwanjang, W3
Abramov, AY2
Chetsawang, B6
Parameyong, A1
Charngkaew, K2
Pan, Y1
Niles, LP2
Chavanich, N1
Mukda, S1
Song, W2
Vincent, B1
Valero, N1
Mosquera, J1
Alcocer, S1
Bonilla, E1
Salazar, J1
Álvarez-Mon, M1
Wongprayoon, P1
Li, M1
Pi, H1
Yang, Z1
Zhang, L1
Li, G1
Tu, M1
Tian, L1
Xie, J1
He, M1
Zhong, M1
Yu, Z1
Beesley, S1
Olcese, J1
Saunders, C1
Bienkiewicz, EA1
González, A1
González-González, A1
Alonso-González, C1
Menéndez-Menéndez, J1
Martínez-Campa, C1
Cos, S2
Chetsawang, J1
Wisessmith, W1
Phansuwan-Pujito, P4
Di Bella, G1
Colori, B1
Tasset, I1
Espínola, C1
Medina, FJ2
Feijóo, M3
Ruiz, C1
Moreno, E1
Gómez, MM1
Collado, JA2
Muñoz, C1
Muntané, J2
Montilla, P3
Túnez, I4
Guo, Y1
Duan, Q1
Romero, A1
García, AG1
López, MG1
Benítez-King, G3
Ortíz-López, L1
Jiménez-Rubio, G1
Ramírez-Rodríguez, G1
Dragicevic, N1
Copes, N1
O'Neal-Moffitt, G1
Jin, J1
Buzzeo, R1
Mamcarz, M1
Tan, J1
Cao, C1
Olcese, JM1
Arendash, GW1
Bradshaw, PC1
Spaeth, CS1
Robison, T1
Fan, JD1
Bittner, GD1
Permpoonputtana, K1
Montilla-López, P1
Muñoz-Agueda, MC1
Feijóo López, M1
Muñoz-Castañeda, JR2
Bujalance-Arenas, I1
Túnez-Fiñana, I1
Mayo, JC1
Sainz, RM1
Antoli, I1
Herrera, F1
Martin, V1
Rodriguez, C1
Weinreb, O1
Mandel, S1
Youdim, MB1
Bellon, A1
Ortíz, GG1
Antón-Tay, F2
Olivieri, G4
Otten, U2
Meier, F3
Baysang, G3
Dimitriades-Schmutz, B2
Müller-Spahn, F4
Savaskan, E3
An, Y1
Liu, E1
Yang, F1
Han, F1
Dai, Q1
Wang, YP3
Li, XT1
Liu, SJ1
Zhou, XW1
Wang, XC3
Wang, JZ5
Li, SP1
Deng, YQ2
Zhang, YC2
Wang, ZF1
Wang, Q1
Muñoz, MC2
Bujalance, I1
Schuster, C1
Williams, LM1
Morris, A1
Morgan, PJ1
Barrett, P1
Xu, GG1
Duan, P1
Gordillo, R1
Sampedro, C1
Moyano, MJ1
McMillan, CR1
Sharma, R1
Ottenhof, T1
Klongpanichapak, S2
Ebadi, M2
Chatterjie, N1
Grundke-Iqbal, I1
Iqbal, K1
Pizarro, JG1
Yeste-Velasco, M1
Esparza, JL1
Verdaguer, E1
Pallàs, M1
Camins, A1
Folch, J1
Huerto-Delgadillo, L1
Meléndez, J1
Maldonado, V1
Ortega, A1
Verduga, R1
Fernández-Viadero, C1
Megías, M1
Crespo, D1
Pappolla, MA3
Sos, M1
Omar, RA2
Bick, RJ1
Hickson-Bick, DL1
Efthimiopoulos, S1
Robakis, NK1
Lahiri, DK4
Lezoualc'h, F1
Sparapani, M1
Behl, C1
Chyan, YJ2
Poeggeler, B2
Chain, DG1
Frangione, B1
Ghiso, J1
Brack, C1
Stähelin, HB1
Herrmann, M1
Renard, P1
Brockhaus, M2
Hock, C1
Ghosh, C1
Davis, D1
Nurnberger, JI1
Bordt, SL1
McKeon, RM1
Li, PK1
Witt-Enderby, PA1
Melan, MA1
Kölsch, H1
Ludwig, M1
Lütjohann, D1
Rao, ML1
Hess, C1
Ly, C1
Simovich, MJ1
Bryant-Thomas, T1
Dubocovich, M1
Bick, R1
Perry, G1
Cruz-Sanchez, F1
Smith, MA1

Reviews

2 reviews available for melatonin and Neuroblastoma

ArticleYear
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022
Melatonin and neuroblastoma: a novel therapeutic approach.
    Molecular biology reports, 2021, Volume: 48, Issue:5

    Topics: Antineoplastic Agents; Child, Preschool; Humans; Melatonin; Neuroblastoma; Pediatrics; Pineal Gland;

2021

Trials

1 trial available for melatonin and Neuroblastoma

ArticleYear
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain;

2022

Other Studies

71 other studies available for melatonin and Neuroblastoma

ArticleYear
New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease.
    European journal of medicinal chemistry, 2015, Oct-20, Volume: 103

    Topics: Alzheimer Disease; Antioxidants; Cell Line, Tumor; Cholinesterase Inhibitors; Cholinesterases; Dose-

2015
New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H
    Journal of medicinal chemistry, 2019, 12-26, Volume: 62, Issue:24

    Topics: Alzheimer Disease; Animals; Calcium Channel Blockers; Cholinesterase Inhibitors; Humans; Memory Diso

2019
Melatonin Attenuates Methamphetamine-Induced Alteration of Amyloid β Precursor Protein Cleaving Enzyme Expressions via Melatonin Receptor in Human Neuroblastoma Cells.
    Neurotoxicity research, 2022, Volume: 40, Issue:4

    Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Pr

2022
Microglial polarization differentially affects neuronal vulnerability to the β-amyloid protein: Modulation by melatonin.
    Biochemical pharmacology, 2022, Volume: 202

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Anti-Inflammatory Agents; Humans; Melatonin; Microglia; Ne

2022
Melatonin attenuates MPP
    Biochemical and biophysical research communications, 2022, 09-17, Volume: 621

    Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; Cell Line, Tumor; Dopaminergic Neurons; Heat-Shock Proteins;

2022
Melatonin-mediated FKBP4 downregulation protects against stress-induced neuronal mitochondria dysfunctions by blocking nuclear translocation of GR.
    Cell death & disease, 2023, 02-21, Volume: 14, Issue:2

    Topics: Animals; Down-Regulation; Glucocorticoids; Humans; Melatonin; Mice; Mitochondria; Neuroblastoma; Rec

2023
Antiviral effect of melatonin on Japanese encephalitis virus infection involves inhibition of neuronal apoptosis and neuroinflammation in SH-SY5Y cells.
    Scientific reports, 2023, 04-13, Volume: 13, Issue:1

    Topics: Animals; Antiviral Agents; Apoptosis; Encephalitis Virus, Japanese; Encephalitis Viruses, Japanese;

2023
Green synthesis, characterization of melatonin-like drug bioconjugated CoS quantum dots and its antiproliferative effect on different cancer cells.
    Molecular biology reports, 2023, Volume: 50, Issue:11

    Topics: Cell Line, Tumor; Humans; Male; Melatonin; Neuroblastoma; Prostatic Neoplasms; Quantum Dots

2023
The role of melatonin in amyloid beta-induced inflammation mediated by inflammasome signaling in neuronal cell lines.
    Scientific reports, 2023, 10-19, Volume: 13, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Caspase 1; Cell Line; Cytokines; Humans; Inflammasomes; In

2023
Polystyrene nanoplastic exposure induces excessive mitophagy by activating AMPK/ULK1 pathway in differentiated SH-SY5Y cells and dopaminergic neurons in vivo.
    Particle and fibre toxicology, 2023, Nov-22, Volume: 20, Issue:1

    Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Autophagy-Related Protein-1 Homolog;

2023
Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer's disease therapy.
    Bioorganic chemistry, 2019, Volume: 91

    Topics: Alzheimer Disease; Antioxidants; Calcium; Calcium Channel Blockers; Calcium Channels; Dihydropyridin

2019
Near-Infrared Responsive Dopamine/Melatonin-Derived Nanocomposites Abrogating in Situ Amyloid β Nucleation, Propagation, and Ameliorate Neuronal Functions.
    ACS applied materials & interfaces, 2020, Feb-05, Volume: 12, Issue:5

    Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Brain; Brain Chemistry; Cell Line, Tumor

2020
Melatonin Prevents Neddylation Dysfunction in Aβ42-Exposed SH-SY5Y Neuroblastoma Cells by Regulating the Amyloid Precursor Protein- Binding Protein 1 Pathway.
    Current Alzheimer research, 2020, Volume: 17, Issue:5

    Topics: Amyloid beta-Peptides; Antioxidants; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Mel

2020
Melatonin Attenuates High Glucose-Induced Changes in Beta Amyloid Precursor Protein Processing in Human Neuroblastoma Cells.
    Neurochemical research, 2022, Volume: 47, Issue:9

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein

2022
Melatonin promotes neuroblastoma cell differentiation by activating hyaluronan synthase 3-induced mitophagy.
    Cancer medicine, 2019, Volume: 8, Issue:10

    Topics: Animals; Autophagy; Cell Differentiation; Cell Line, Tumor; Gene Expression Regulation, Neoplastic;

2019
Oxidative stress and related gene expression effects of cyfluthrin in human neuroblastoma SH-SY5Y cells: Protective effect of melatonin.
    Environmental research, 2019, Volume: 177

    Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Dual Oxidases; Gene Expression; Humans; Insecticides; Me

2019
Melatonin attenuates dexamethasone toxicity-induced oxidative stress, calpain and caspase activation in human neuroblastoma SH-SY5Y cells.
    The Journal of steroid biochemistry and molecular biology, 2013, Volume: 138

    Topics: Blotting, Western; Calpain; Caspases; Cell Line, Tumor; Cell Survival; Dexamethasone; Humans; Melato

2013
Melatonin attenuates methamphetamine-induced disturbances in mitochondrial dynamics and degeneration in neuroblastoma SH-SY5Y cells.
    Journal of pineal research, 2013, Volume: 55, Issue:3

    Topics: Cell Death; Cell Line, Tumor; Central Nervous System Depressants; Central Nervous System Stimulants;

2013
Epigenetic mechanisms of melatonin action in human SH-SY5Y neuroblastoma cells.
    Molecular and cellular endocrinology, 2015, Feb-15, Volume: 402

    Topics: Acetylation; Cell Line, Tumor; Chromatin Assembly and Disassembly; Epigenesis, Genetic; Gene Express

2015
Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells.
    Journal of pineal research, 2015, Volume: 59, Issue:3

    Topics: ADAM Proteins; ADAM10 Protein; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic

2015
Melatonin, minocycline and ascorbic acid reduce oxidative stress and viral titers and increase survival rate in experimental Venezuelan equine encephalitis.
    Brain research, 2015, Oct-05, Volume: 1622

    Topics: Animals; Antiviral Agents; Ascorbic Acid; Brain; Cell Line, Tumor; Disease Models, Animal; Dose-Resp

2015
Melatonin attenuates methamphetamine-induced neuroinflammation through the melatonin receptor in the SH-SY5Y cell line.
    Neurotoxicology, 2015, Volume: 50

    Topics: Antioxidants; Cell Line, Tumor; Central Nervous System Stimulants; Culture Media, Serum-Free; Gene E

2015
Melatonin prevents cytosolic calcium overload, mitochondrial damage and cell death due to toxically high doses of dexamethasone-induced oxidative stress in human neuroblastoma SH-SY5Y cells.
    Neurochemistry international, 2016, Volume: 97

    Topics: Calcium; Cell Death; Cell Line, Tumor; Cytosol; Dexamethasone; Dose-Response Relationship, Drug; Hum

2016
Melatonin antagonizes cadmium-induced neurotoxicity by activating the transcription factor EB-dependent autophagy-lysosome machinery in mouse neuroblastoma cells.
    Journal of pineal research, 2016, Volume: 61, Issue:3

    Topics: Active Transport, Cell Nucleus; Animals; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcript

2016
Combinatorial Treatment Effects in a Cell Culture Model of Alzheimer's Disease.
    Journal of Alzheimer's disease : JAD, 2017, Volume: 55, Issue:3

    Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antipsychotic Agents; Catechin; Cell

2017
Melatonin inhibits angiogenesis in SH-SY5Y human neuroblastoma cells by downregulation of VEGF.
    Oncology reports, 2017, Volume: 37, Issue:4

    Topics: Angiogenesis Inhibitors; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cells, Cultured; Cocul

2017
Protection against cell death and sustained tyrosine hydroxylase phosphorylation in hydrogen peroxide- and MPP-treated human neuroblastoma cells with melatonin.
    Journal of pineal research, 2009, Volume: 46, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Analysis of Variance; Blotting, Western; Cell Death; Cell Line, Tumor;

2009
Melatonin reduces induction of Bax, caspase and cell death in methamphetamine-treated human neuroblastoma SH-SY5Y cultured cells.
    Journal of pineal research, 2009, Volume: 46, Issue:4

    Topics: bcl-2-Associated X Protein; Caspase 3; Cell Count; Cell Death; Cell Line, Tumor; Cell Survival; Desi

2009
Complete objective response of neuroblastoma to biological treatment.
    Neuro endocrinology letters, 2009, Volume: 30, Issue:4

    Topics: Antioxidants; Drug Therapy, Combination; Humans; Infant; Magnetic Resonance Imaging; Male; Melatonin

2009
The protective effect of melatonin on methamphetamine-induced calpain-dependent death pathway in human neuroblastoma SH-SY5Y cultured cells.
    Journal of pineal research, 2010, Volume: 48, Issue:2

    Topics: Calcium-Binding Proteins; Calpain; Cell Line, Tumor; Cell Survival; Humans; Melatonin; Methamphetami

2010
Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma.
    Journal of physiology and biochemistry, 2009, Volume: 65, Issue:3

    Topics: Animals; Carbazoles; Carvedilol; Free Radical Scavengers; Glutathione; L-Lactate Dehydrogenase; Lipi

2009
Melatonin protects N2a against ischemia/reperfusion injury through autophagy enhancement.
    Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2010, Volume: 30, Issue:1

    Topics: Animals; Autophagy; Cell Hypoxia; Cell Line, Tumor; Melatonin; Mice; Neuroblastoma; Neuroprotective

2010
Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells.
    Journal of pineal research, 2010, Volume: 49, Issue:2

    Topics: Analysis of Variance; Cell Death; Cell Line, Tumor; Drug Synergism; Galantamine; Histocytochemistry;

2010
Haloperidol causes cytoskeletal collapse in N1E-115 cells through tau hyperphosphorylation induced by oxidative stress: Implications for neurodevelopment.
    European journal of pharmacology, 2010, Oct-10, Volume: 644, Issue:1-3

    Topics: Animals; Antioxidants; Antipsychotic Agents; Cell Line, Tumor; Cytoskeleton; Dose-Response Relations

2010
Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling.
    Journal of pineal research, 2011, Volume: 51, Issue:1

    Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Ani

2011
Cellular mechanisms of plasmalemmal sealing and axonal repair by polyethylene glycol and methylene blue.
    Journal of neuroscience research, 2012, Volume: 90, Issue:5

    Topics: Animals; Antioxidants; Axons; Axotomy; Calcium; Cell Line, Tumor; Cell Membrane; Disease Models, Ani

2012
The anti-inflammatory effect of melatonin on methamphetamine-induced proinflammatory mediators in human neuroblastoma dopamine SH-SY5Y cell lines.
    Neurotoxicity research, 2013, Volume: 23, Issue:2

    Topics: Analysis of Variance; Anti-Inflammatory Agents; Cell Line, Tumor; Cell Survival; Central Nervous Sys

2013
Comparison of melatonin versus vitamin C on oxidative stress and antioxidant enzyme activity in Alzheimer's disease induced by okadaic acid in neuroblastoma cells.
    European journal of pharmacology, 2002, Sep-20, Volume: 451, Issue:3

    Topics: Alzheimer Disease; Animals; Ascorbic Acid; Catalase; Glutathione Transferase; Lipid Peroxidation; Me

2002
Melatonin regulation of antioxidant enzyme gene expression.
    Cellular and molecular life sciences : CMLS, 2002, Volume: 59, Issue:10

    Topics: Animals; Antioxidants; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplast

2002
cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2003, Volume: 17, Issue:8

    Topics: Antioxidants; Apomorphine; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Catechin; Cel

2003
Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in N1E-115 cells.
    Experimental neurology, 2003, Volume: 182, Issue:1

    Topics: Animals; Cytoskeleton; Dose-Response Relationship, Drug; Enzyme Inhibitors; Melatonin; Mice; Microtu

2003
Beta-amyloid modulates tyrosine kinase B receptor expression in SHSY5Y neuroblastoma cells: influence of the antioxidant melatonin.
    Neuroscience, 2003, Volume: 120, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Blotting, Western; Brain-Derived Ne

2003
Protective effect of melatonin on neural cells against the cytotoxicity of oxyradicals.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2000, Volume: 15, Issue:1

    Topics: Amyloid beta-Peptides; Apoptosis; Cell Survival; Free Radical Scavengers; Glioblastoma; Glutathione;

2000
Melatonin ameliorated okadaic-acid induced Alzheimer-like lesions.
    Acta pharmacologica Sinica, 2004, Volume: 25, Issue:3

    Topics: Alzheimer Disease; Cell Survival; Humans; Melatonin; Microtubules; Mitochondria; Neuroblastoma; Neur

2004
Melatonin protects SH-SY5Y neuroblastoma cells from calyculin A-induced neurofilament impairment and neurotoxicity.
    Journal of pineal research, 2004, Volume: 36, Issue:3

    Topics: Cell Survival; Enzyme Inhibitors; Humans; Marine Toxins; Melatonin; Neuroblastoma; Neurofilament Pro

2004
Melatonin attenuates beta-amyloid-induced inhibition of neurofilament expression.
    Acta pharmacologica Sinica, 2004, Volume: 25, Issue:4

    Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Melatonin; Mice; Neuroblastoma; Neur

2004
Effect of melatonin on the oxidative stress in N1E-115 cells is not mediated by mt1 receptors.
    Journal of physiology and biochemistry, 2003, Volume: 59, Issue:4

    Topics: Animals; Cell Line, Tumor; Enzyme Inhibitors; Lipid Peroxidation; Melatonin; Mice; Neuroblastoma; Ok

2003
The human MT1 melatonin receptor stimulates cAMP production in the human neuroblastoma cell line SH-SY5Y cells via a calcium-calmodulin signal transduction pathway.
    Journal of neuroendocrinology, 2005, Volume: 17, Issue:3

    Topics: Calcium-Calmodulin-Dependent Protein Kinases; Colforsin; Cyclic AMP; Enzyme Activators; GTP-Binding

2005
Effects of melatonin on wortmannin-induced tau hyperphosphorylation.
    Acta pharmacologica Sinica, 2005, Volume: 26, Issue:5

    Topics: Androstadienes; Apoptosis; Cell Line, Tumor; Cell Survival; Glycogen Synthase Kinase 3; Glycogen Syn

2005
Protective effect of carvedilol on oxidative stress induced by okadaic acid in N1E-115 cells.
    Pharmacological research, 2006, Volume: 54, Issue:3

    Topics: Animals; Carbazoles; Carvedilol; Catalase; Cell Line, Tumor; Drug Interactions; Glutathione; Glutath

2006
Modulation of tyrosine hydroxylase expression by melatonin in human SH-SY5Y neuroblastoma cells.
    Neuroscience letters, 2007, Jun-04, Volume: 419, Issue:3

    Topics: Blotting, Western; Cell Differentiation; Cell Line, Tumor; Dose-Response Relationship, Drug; Gene Ex

2007
Melatonin protects SK-N-SH neuroblastoma cells from amphetamine-induced neurotoxicity.
    Journal of pineal research, 2007, Volume: 43, Issue:1

    Topics: Cell Line, Tumor; Dextroamphetamine; Humans; Melatonin; Neuroblastoma; Neurons

2007
Effect of melatonin and melatonylvalpromide on beta-amyloid and neurofilaments in N2a cells.
    Neurochemical research, 2008, Volume: 33, Issue:6

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Line, Tumor; Melatonin; Mice; Neuroblastoma;

2008
The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes.
    Journal of pineal research, 2008, Volume: 45, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dopamine;

2008
Melatonin inhibits amphetamine-induced increase in alpha-synuclein and decrease in phosphorylated tyrosine hydroxylase in SK-N-SH cells.
    Neuroscience letters, 2008, May-16, Volume: 436, Issue:3

    Topics: alpha-Synuclein; Amphetamine; Antioxidants; Cell Line, Tumor; Central Nervous System Stimulants; Dos

2008
Effects of melatonin on microtubule assembly depend on hormone concentration: role of melatonin as a calmodulin antagonist.
    Journal of pineal research, 1994, Volume: 17, Issue:2

    Topics: Animals; Calcium; Calmodulin; Dose-Response Relationship, Drug; Melatonin; Mice; Microtubules; Neuro

1994
Effect of melatonin on beta-tubulin and MAP2 expression in NIE-115 cells.
    Neurochemical research, 1996, Volume: 21, Issue:6

    Topics: Biopolymers; Melatonin; Microtubule-Associated Proteins; Neurites; Neuroblastoma; Neurons; Solubilit

1996
Effects of melatonin on the proliferation and differentiation of human neuroblastoma cells in culture.
    Neuroscience letters, 1996, Sep-27, Volume: 216, Issue:2

    Topics: Analysis of Variance; Cell Differentiation; Cell Division; Cell Nucleus; Cell Size; Humans; Melatoni

1996
Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1997, Mar-01, Volume: 17, Issue:5

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Apoptosis; Calcium; Ditiocarb; Doxo

1997
Melatonin alters the metabolism of the beta-amyloid precursor protein in the neuroendocrine cell line PC12.
    Journal of molecular neuroscience : MN, 1997, Volume: 9, Issue:2

    Topics: Amyloid beta-Protein Precursor; Animals; Antioxidants; Blotting, Northern; Cell Differentiation; Est

1997
N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-kappaB.
    Journal of pineal research, 1998, Volume: 24, Issue:3

    Topics: Animals; Cell Survival; Cerebellar Nuclei; Electrophoresis, Polyacrylamide Gel; Glutamic Acid; Hydro

1998
Melatonin affects the metabolism of the beta-amyloid precursor protein in different cell types.
    Journal of pineal research, 1999, Volume: 26, Issue:3

    Topics: Amyloid beta-Protein Precursor; Animals; Carbachol; Cell Line; Culture Media, Conditioned; Dose-Resp

1999
Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid.
    The Journal of biological chemistry, 1999, Jul-30, Volume: 274, Issue:31

    Topics: Amyloid beta-Peptides; Animals; Antioxidants; Cell Survival; Cells, Cultured; Fetus; Hippocampus; Hu

1999
Mercury induces cell cytotoxicity and oxidative stress and increases beta-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells.
    Journal of neurochemistry, 2000, Volume: 74, Issue:1

    Topics: Amyloid beta-Peptides; Cell Survival; Drug Combinations; Glutathione; Melatonin; Mercuric Chloride;

2000
Interactions between melatonin, reactive oxygen species, and nitric oxide.
    Annals of the New York Academy of Sciences, 1999, Volume: 893

    Topics: Animals; Benzoates; Cerebellum; Imidazoles; Kinetics; Melatonin; Neuroblastoma; Nitric Oxide; Nitric

1999
Detection of specific protein bands with melatonin-like immunoreactivity in different cell lines and human brain regions.
    IUBMB life, 1999, Volume: 48, Issue:1

    Topics: Animals; Blotting, Western; Brain Chemistry; Cell Line; Humans; Macrophages; Melatonin; Mice; Neurob

1999
N1E-115 mouse neuroblastoma cells express MT1 melatonin receptors and produce neurites in response to melatonin.
    Biochimica et biophysica acta, 2001, Jan-15, Volume: 1499, Issue:3

    Topics: Animals; Iodine Radioisotopes; Kinetics; Melatonin; Mice; Mitogen-Activated Protein Kinase Kinases;

2001
Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17beta.
    Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:4

    Topics: Antioxidants; Ascorbic Acid; Brain; Caspase 3; Caspases; Estradiol; Free Radicals; Humans; Hydroxych

2001
Melatonin protects SHSY5Y neuroblastoma cells from cobalt-induced oxidative stress, neurotoxicity and increased beta-amyloid secretion.
    Journal of pineal research, 2001, Volume: 31, Issue:4

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cobalt; Glutathione; Humans; Melatonin; Neuroblas

2001
Oxidative stress modulates tyrosine kinase receptor A and p75 receptor (low-affinity nerve growth factor receptor) expression in SHSY5Y neuroblastoma cells.
    Neurology & clinical neurophysiology : NCN, 2002, Volume: 2002, Issue:2

    Topics: Amyloid beta-Peptides; Antioxidants; Cell Line; Cell Survival; Gene Expression Regulation, Neoplasti

2002
The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors.
    Journal of pineal research, 2002, Volume: 32, Issue:3

    Topics: 5-Methoxytryptamine; Amyloid beta-Peptides; Animals; Antioxidants; Cells, Cultured; Cyclic N-Oxides;

2002